Finally, mutations in ASXL1, SRSF2, and the RAS pathway, which were found in our patient, are independently associated with the myeloproliferative subtype of CMML and a poor prognosis [3]. The gene discussed is SRSF2; the disease is chronic myelomonocytic leukemia.